Type 2 diabetes and the risk of mortality among patients with prostate cancer.
about
Diabetes and mortality in patients with prostate cancer: a meta-analysisTall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.The diabetes-cancer linkClinical management and burden of prostate cancer: a Markov Monte Carlo model.Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study.The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study.Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies.Common medications and prostate cancer mortality: a review.Insights into the relationships between diabetes, prediabetes, and cancer.Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer.Metformin and prostate cancer mortality: a meta-analysis.Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau).A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus.TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer
P2860
Q28072665-09D00C65-51CC-4334-8AA4-BDDAE813416DQ33901167-B670089C-6EA5-451A-BB82-E03634B4F7A0Q34510892-B1EF059B-70DE-4C85-99BE-9969A8C642D7Q34634410-210DEEF1-442E-4CB9-8B21-4827855681D4Q36278009-8DE91EC0-131B-4B7F-BE29-9F3E792D0161Q37662211-63474AFA-BC08-4309-8486-1E8947A53CBAQ38234432-DBF1E3CC-CF2D-41C8-84A6-E54D557F68EDQ38918805-45E0FCFA-4512-4DF7-9345-85C0FCD861E2Q39063925-59E7AED1-3D22-490C-8AB6-C9F8209AD7CDQ40382361-60ED6E49-7AD5-4A3F-B3A2-21652C45B8BDQ40782810-F4F2E30B-66AC-4FAB-83C0-7DEE585B605AQ41149937-FBC94A2B-F39F-487B-BDDE-5E229D39CAA1Q44441338-D018904A-4284-41A7-8D53-ABBF45E882DDQ49884540-1AC2C8B8-2551-409D-9146-36B7DA425499Q51320229-3C25079D-0769-4069-9601-3554D80C4ECBQ58773054-C3994A37-A30C-420C-ACD9-90272D367E16
P2860
Type 2 diabetes and the risk of mortality among patients with prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Type 2 diabetes and the risk of mortality among patients with prostate cancer.
@en
Type 2 diabetes and the risk of mortality among patients with prostate cancer.
@nl
type
label
Type 2 diabetes and the risk of mortality among patients with prostate cancer.
@en
Type 2 diabetes and the risk of mortality among patients with prostate cancer.
@nl
prefLabel
Type 2 diabetes and the risk of mortality among patients with prostate cancer.
@en
Type 2 diabetes and the risk of mortality among patients with prostate cancer.
@nl
P2093
P2860
P1476
Type 2 diabetes and the risk of mortality among patients with prostate cancer.
@en
P2093
Laurent Azoulay
Leah Bensimon
Michael N Pollak
Samy Suissa
P2860
P2888
P304
P356
10.1007/S10552-013-0334-6
P577
2014-01-03T00:00:00Z
P5875
P6179
1012432240